Literature DB >> 12085512

Overseeing research on therapeutic cloning: a private ethics board responds to its critics.

Ronald M Green, Kier Olsen DeVries, Judith Bernstein, Kenneth W Goodman, Robert Kaufmann, Ann A Kiessling, Susan R Levin, Susan L Moss, Carol A Tauer.   

Abstract

Advanced Cell Technology's Ethics Advisory Board has been called window dressing for a corporate marketing plan. But the scientists and managers have paid attention, and the lawyers have gone along.

Keywords:  Advanced Cell Technology Inc.; Biomedical and Behavioral Research; Genetics and Reproduction

Mesh:

Year:  2002        PMID: 12085512

Source DB:  PubMed          Journal:  Hastings Cent Rep        ISSN: 0093-0334            Impact factor:   2.683


  2 in total

1.  Withholding artificial feeding from the severely demented: merciful or immoral? Contrasts between secular and Jewish perspectives.

Authors:  J Kunin
Journal:  J Med Ethics       Date:  2003-08       Impact factor: 2.903

2.  Therapeutic cloning research and ethical oversight.

Authors:  M Spriggs
Journal:  J Med Ethics       Date:  2003-08       Impact factor: 2.903

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.